Ottawa – An important part of the Government of Canada’s public health approach to legalizing and strictly regulating cannabis is ongoing and comprehensive surveillance, data collection and evidence gathering. The results from the annual Canadian Cannabis Survey provide a snapshot of public health and public safety data on cannabis in Canada. Health Canda published the 2024 Canadian Cannabis Survey (CCS) results. …
Québec – The Government of Canada is investing in a robust, dynamic and resilient life sciences ecosystem capable of responding to current and future health emergencies. Since March 2020, over $2.2 billion has been invested to strengthen domestic biomanufacturing capabilities and help keep Canadians healthy and safe. Jean-Yves Duclos, Minister of Public Services and Procurement and Quebec Lieutenant, on behalf of …
St. Catharines – The overdose crisis is one of the most serious public health crises our country has ever faced. It is driven by a dangerous illegal synthetic drug supply that is unpredictable and increasingly toxic. Too many Canadians have lost their lives to this public health crisis. Canada’s approach is focused on providing access to a full continuum of …
Ottawa – One of Health Canada’s mandates is to reduce the incidence of disease and conditions among Canadians. Many science and health experts research and monitor diseases and you’ll find many of their reports and publications in this section. You’ll find information about many diseases and conditions, including their symptoms and treatments. Because healthy lifestyle choices reduce the risk of …
Ottawa – The latest edition of Meds Pipeline Monitor, from the Patented Medicine Prices Review Board, provides stakeholders with a list of new medicines in the late stages of clinical evaluation that may significantly impact clinical practice or drug spending in the coming years. There were over 12,000 drugs in the pipeline in 2023, increasing by an average of 19% per …
Ottawa, ON | Health Canada No community has been left untouched by the toxic drug and overdose crisis. Its tragic impacts are felt among friends, families and neighbours. Too many Canadians have lost their lives to this public health crisis. Canada’s approach is focused on providing access to a full continuum of health care services and leveraging every tool at …
Ottawa – The Government of Canada is taking steps to implement the modernized Canadian Environmental Protection Act, 1999 (CEPA), which recognizes in its preamble that every individual in Canada has a right to a healthy environment as provided under CEPA. It also strengthens Canada’s chemicals management regime and increases transparency in the way it is administered. Through the strengthening of CEPA, …
Ottawa – Everyone in Canada deserves a health system that provides each of us with access to the services we need, when and where we need them. The availability and types of mental health and substance use supports can vary across Canada, which can lead to inconsistencies in quality and accessibility. To help address this challenge, Health Canada commissioned the …
Product description Brand name COMIRNATY that has been approved recently by Health Canada Company name BioNTech Manufacturing GmbH Ingredient mRNA encoding SARS-CoV-2 spike protein, 5’ [m27,3’-OGppp(m12’-O)ApG] cap, 110-nucleotide 3′ poly(A) tail with a 10-nucleotide linker sequence. This product (COMIRNATY) includes an update to the antigen composition (variant Omicron KP.2) and replaces COMIRNATY Omicron XBB.1.5 (raxtozinameran).
Ottawa – Several vaccines for COVID-19 are authorized and available for use in Canada. These include messenger ribonucleic acid (mRNA) vaccines (preferred) and a protein subunit vaccine. The XBB.1.5 vaccines are now the recommended products. Refer to Preparations authorized for use in Canada for more information. Novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …
